Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2026-03-17 @ 12:59 PM
Study NCT ID:
NCT07128550
Status:
RECRUITING
Last Update Posted:
2025-11-12
First Post:
2025-08-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide
Sponsor:
Vir Biotechnology, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VIR-CHDV-V205
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None